Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar ...

SHENZHEN, GUANGDONG, CHINA, July 29, 2026 /EINPresswire.com/ -- Trust serves as the primary currency in the modern ...

Glioblastoma (GBM) is a devastating and highly malignant primary brain tumor, characterized by its aggressive growth and ...

Rapid oral presentation to highlight overall survival data from the DENALI Part 1b study of azenosertibSAN DIEGO, July 17, 2026 (GLOBE ...

Atossa Therapeutics, Inc. (NASDAQ: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical ...

A jellyfish that measures roughly 4.5 mm across, smaller than a human fingernail, can do something no other known animal ...

A subset of cancers, known as microsatellite instability (MSI) and deficient DNA mismatch repair (dMMR) cancers, are more visible to the immune system than others. Because their DNA repair systems are ...

A 70-year-old man with a past medical history of hypertension presents with a changing lesion and a complaint of a mole on his upper arm.

Alan Murray, Co-founder and CEO, Conceivable Life Sciences - is an engineer and serial entrepreneur with more than three decades of experience spanning technology, machine learning, hardware, ...

Radiopharmaceutical therapy (RPT) delivers protracted, low absorbed dose rate radiation over time, with cellular DNA repair ...

Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics webcast to discuss recent clinical ...

Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe, and good evening to those listening in Asia. Welcome to AstraZeneca's Half 1 and Q2 2026 Webinar for ...